NVO
Ticker
Novo Nordisk (DKK)
Company
Biopharma
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
19.0%9.2%17.6%7.1%6.3%21.5%3.6%-0.1%0.1%9.1%4.0%10.9%25.7%31.3%25.0% 20.9%
Revenue Growth QoQ
Gross Margin
79.6%80.8%81.0%82.7%83.1%83.6%85.0%84.6%84.2%84.2%83.5%83.5%83.2%83.9%84.6%84.7% 83.9%
EBITDA Margin
34.2%35.1%37.8%41.2%41.0%42.7%48.6%46.2%46.7%45.8%47.7%47.2%45.9%46.4%48.2%50.8% 50.9%
Operating Margin
29.2%31.1%33.7%37.8%37.7%38.8%45.8%43.3%43.8%42.2%43.0%42.6%41.7%42.3%44.2%44.2% 45.8%
Profit Margin
21.1%23.7%25.8%27.5%30.1%29.8%32.3%33.9%34.1%34.5%31.9%33.2%33.9%31.4%36.0%34.8% 35.6%
FCF / EBITDA
71.8%73.9%71.8%57.8%65.0%72.1%60.8%77.6%62.4%62.9%61.1%49.9%73.6%78.0%62.5%47.2% 38.8%